Anna Tesei

4.8k total citations · 1 hit paper
110 papers, 3.6k citations indexed

About

Anna Tesei is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Tesei has authored 110 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 41 papers in Oncology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Tesei's work include Cancer therapeutics and mechanisms (14 papers), Cancer Cells and Metastasis (11 papers) and Cell Image Analysis Techniques (10 papers). Anna Tesei is often cited by papers focused on Cancer therapeutics and mechanisms (14 papers), Cancer Cells and Metastasis (11 papers) and Cell Image Analysis Techniques (10 papers). Anna Tesei collaborates with scholars based in Italy, United States and Germany. Anna Tesei's co-authors include Chiara Arienti, Michele Zanoni, Filippo Piccinini, Alice Zamagni, Alessandro Bevilacqua, Wainer Zoli, Sara Pignatta, R. Polico, Spartaco Santi and Dino Amadori and has published in prestigious journals such as PLoS ONE, Nature Reviews Drug Discovery and Cancer Research.

In The Last Decade

Anna Tesei

107 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained

2016 838 citations Michele Zanoni, Filippo Piccinini et al. Scientific Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Tesei Italy	30	1.4k	1.2k	881	556	529	110	3.6k
Chris van Bree Netherlands	18	2.3k 1.6×	1.2k 1.0×	696 0.8×	622 1.1×	793 1.5×	47	4.4k
Satoshi Kashiwagi United States	27	1.5k 1.0×	602 0.5×	938 1.1×	349 0.6×	473 0.9×	75	4.0k
Christine Unger Austria	24	1.6k 1.1×	1.1k 0.9×	635 0.7×	237 0.4×	492 0.9×	34	3.3k
D J Chaplin United Kingdom	19	1.4k 0.9×	740 0.6×	482 0.5×	440 0.8×	1.0k 2.0×	33	3.0k
Gabriel Helmlinger United States	23	1.7k 1.2×	743 0.6×	896 1.0×	391 0.7×	809 1.5×	65	4.1k
Chiara Arienti Italy	20	717 0.5×	788 0.6×	742 0.8×	230 0.4×	281 0.5×	42	2.0k
Claire Rodriguez‐Lafrasse France	40	1.9k 1.3×	563 0.5×	479 0.5×	1.0k 1.9×	587 1.1×	124	4.3k
Helmut Dolznig Austria	36	2.3k 1.6×	1.7k 1.4×	833 0.9×	329 0.6×	823 1.6×	86	4.7k
Michael Schirner Germany	35	1.6k 1.1×	1.0k 0.8×	580 0.7×	214 0.4×	454 0.9×	101	4.2k
Chao‐Kai Chou Taiwan	29	2.8k 2.0×	1.5k 1.3×	419 0.5×	362 0.7×	397 0.8×	77	5.2k

Countries citing papers authored by Anna Tesei

Since Specialization

Citations

This map shows the geographic impact of Anna Tesei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tesei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tesei more than expected).

Fields of papers citing papers by Anna Tesei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tesei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tesei. The network helps show where Anna Tesei may publish in the future.

Co-authorship network of co-authors of Anna Tesei

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tesei. A scholar is included among the top collaborators of Anna Tesei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tesei. Anna Tesei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Serra, Patrizia, Giorgia Simonetti, Alessio Porta, et al.. (2025). Preparation of a Micronutrient-Enriched Apricot Kernel Oil and Assessment of In Vitro Chemopreventive Properties. International Journal of Molecular Sciences. 26(18). 9237–9237.

Piccinini, Filippo, et al.. (2023). Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance. Cells. 12(5). 802–802. 39 indexed citations

Tesei, Anna, Michela Cortesi, Giacomo Rossino, et al.. (2022). Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer. Molecules. 27(14). 4327–4327. 3 indexed citations

Donato, Marzia Di, Alice Zamagni, Giovanni Galasso, et al.. (2021). Correction to: The androgen receptor/filamin A complex as a target in prostate cancer microenvironment. Cell Death and Disease. 12(3). 272–272. 3 indexed citations

Donato, Marzia Di, Alice Zamagni, Giovanni Galasso, et al.. (2021). The androgen receptor/filamin A complex as a target in prostate cancer microenvironment. Cell Death and Disease. 12(1). 127–127. 55 indexed citations

Foca, Flavia, et al.. (2020). Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy. Scientific Reports. 10(1). 19321–19321. 5 indexed citations

Storci, Gianluca, Sabrina De Carolis, Alessio Papi, et al.. (2019). Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians. Cell Death and Differentiation. 26(9). 1845–1858. 45 indexed citations

Tesei, Anna, Michela Cortesi, Alice Zamagni, et al.. (2018). Sigma Receptors as Endoplasmic Reticulum Stress “Gatekeepers” and their Modulators as Emerging New Weapons in the Fight Against Cancer. Frontiers in Pharmacology. 9. 711–711. 51 indexed citations

Carragher, Neil O., Filippo Piccinini, Anna Tesei, et al.. (2018). Concerns, challenges and promises of high-content analysis of 3D cellular models. Nature Reviews Drug Discovery. 17(8). 606–606. 65 indexed citations

10.

Carloni, Silvia, Giulia Gallerani, Anna Tesei, et al.. (2017). DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy. OncoTargets and Therapy. Volume 10. 4657–4664. 3 indexed citations

11.

Collina, Simona, Marta Rui, Daniela Rossi, et al.. (2017). Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016). Expert Opinion on Therapeutic Patents. 27(5). 565–578. 14 indexed citations

12.

Zanoni, Michele, Filippo Piccinini, Chiara Arienti, et al.. (2016). 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Scientific Reports. 6(1). 19103–19103. 838 indexed citations breakdown →

13.

Pignatta, Sara, Chiara Arienti, Wainer Zoli, et al.. (2013). Prolonged exposure to ( R )-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome. Molecular and Cellular Endocrinology. 382(1). 314–324. 12 indexed citations

14.

Tesei, Anna, Carlo Leonetti, Marzia Di Donato, et al.. (2013). Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models. PLoS ONE. 8(5). e62657–e62657. 15 indexed citations

15.

Vannini, Ivan, Wainer Zoli, Francesco� Fabbri, et al.. (2009). Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines. Anti-Cancer Drugs. 20(10). 918–925. 12 indexed citations

16.

Ulivi, Paola, Chiara Arienti, Anna Tesei, et al.. (2008). Different mechanisms involved in the activity of BAY 43-9006 (Sorafenib) in human pancreatic cancer cell lines. Cancer Research. 68. 2809–2809. 1 indexed citations

17.

Fabbri, Francesco�, Giovanni Brigliadori, Silvia Carloni, et al.. (2008). Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line. Journal of Translational Medicine. 6(1). 43–43. 23 indexed citations

18.

Arienti, Chiara, Anna Tesei, Alberto Ravaioli, et al.. (2008). Activity of lipoplatin in tumor and in normal cells in vitro. Anti-Cancer Drugs. 19(10). 983–990. 21 indexed citations

19.

Tesei, Anna, Marco Rosetti, Paola Ulivi, et al.. (2007). Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines. Journal of Translational Medicine. 5(1). 52–52. 22 indexed citations

20.

Ricotti, Luca, Anna Tesei, Carlo Milandri, et al.. (2003). Potentiation of Antiproliferative Drug Activity by Lonidamine in Hepatocellular Carcinoma Cells. Journal of Chemotherapy. 15(5). 480–487. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact